Public limited company · Gent · incorporated on 10/07/2020 · 41,2 ETP
| 2025 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,4 M € | +69.1% | 1,4 M € | +144.3% | -3,2 M € | -47.2% | -2,2 M € | |
| EBITDA | -1,4 M € | +30.4% | -2,1 M € | +62.0% | -5,5 M € | -47.9% | -3,7 M € | |
| Operating profit | -11,8 M € | -6.2% | -11,1 M € | -99.7% | -5,6 M € | -49.5% | -3,7 M € | |
| Profit/loss | -11,8 M € | -10.0% | -10,7 M € | -89.3% | -5,6 M € | -50.5% | -3,8 M € | |
| Equity | 5,9 M € | -19.4% | 7,3 M € | -59.3% | 18,0 M € | -23.4% | 23,5 M € | |
| Total assets | 9,5 M € | -47.9% | 18,2 M € | -14.0% | 21,2 M € | -19.5% | 26,3 M € | |
| Cash | 733,8 k € | -85.5% | 5,1 M € | -22.3% | 6,5 M € | -71.6% | 23,0 M € | |
| Debts | 3,4 M € | -63.7% | 9,5 M € | +198.0% | 3,2 M € | +13.2% | 2,8 M € | |
| Staff | 41,2 | 42,3 | 30,5 | 16,5 | ||||
Public limited company loss-making in the latest fiscal year. Cash position declining (-85.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Ziphius is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Gent. It employs on average 41,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette